During 2025, the FDA inspected five drug companies in Oklahoma, conducting one inspection at each facility, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the third lowest count for a single company type in Oklahoma, accounting for 3.5% of all FDA inspections conducted in the state that year.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 7 | — | — |
| Blood and Blood Products | 4 | 1 | — |
| Compliance: Devices | 3 | 3 | 1 |
| Food Composition, Standards, Labeling and Econ | 4 | 2 | — |
| Foodborne Biological Hazards | 92 | 11 | 1 |
| Human Cellular, Tissue, and Gene Therapies | 7 | 1 | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 4 | 1 | — |
| Postmarket Assurance: Devices | 3 | 2 | 1 |
| Technical Assistance: Food and Cosmetics | 10 | 6 | — |
| Tobacco Post-Market Activities | — | 2 | — |
